XOMA Corporation(XOMAP)Earnings, Financials & Key Ratios

XOMAP•NASDAQ

$25.32

$306M mkt cap·17.3× P/E·Price updated May 6, 2026

SectorHealthcare IndustryBiotechnology Sub-IndustryRoyalty and IP Monetization Vehicles

AboutXOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.Show more

Revenue$52M+83.1%
EBITDA$14M+136.1%
Net Income$32M+329.4%
EPS (Diluted)1.46+188.5%
Gross Margin94.32%-5.0%
EBITDA Margin27.53%+119.7%
Operating Margin21.83%+115.6%
Net Margin60.81%+225.3%
ROE34.12%+310.6%
ROIC6.77%+118.0%
Debt/Equity1.27-13.0%
Interest Coverage0.87+314.4%

Technical→

XOMAP Key Insights

XOMA Corporation (XOMAP) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong 5Y profit CAGR of 19.0%
✓Strong 5Y sales CAGR of 12.2%

✗Weaknesses

✗Low quality earnings: Net income not backed by cash flow
✗Shares diluted 53.7% in last year
✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

XOMAP Price & Volume

XOMA Corporation (XOMAP) stock price & volume — 10-year historical chart

Loading chart...

XOMAP Growth Metrics

XOMA Corporation (XOMAP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-0.61%

5 Years12.16%

3 Years105.3%

TTM83.06%

Profit CAGR

10 Years-

5 Years18.98%

3 Years-

TTM329.45%

EPS CAGR

10 Years-

5 Years13.36%

3 Years-

TTM344.44%

Return on Capital

10 Years-22.21%

5 Years-7.44%

3 Years-12.74%

Last Year5.24%

XOMAP Recent Earnings

XOMA Corporation (XOMAP) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 4/12 qtrs (80%)●Beat Revenue 3/12 qtrs (60%)

Q2 2026Latest

Mar 18, 2026

EPS

$0.26

Est $0.11

+327.0%

Revenue

$14M

Est $11M

+24.5%

Q4 2025

Nov 12, 2025

EPS

$0.78

Est $0.04

+2050.0%

Revenue

$9M

Est $11M

-18.5%

Q3 2025

Aug 15, 2025

EPS

$0.61

Est $0.15

+508.7%

Revenue

$13M

Est $11M

+19.4%

Q2 2025

May 13, 2025

EPS

$0.20

Est $0.24

+183.2%

Revenue

$16M

Est $8M

+101.0%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Mar 18, 2026	$0.26vs $0.11+327.0%	$14Mvs $11M+24.5%
Q4 2025	Nov 12, 2025	$0.78vs $0.04+2050.0%	$9Mvs $11M-18.5%
Q3 2025	Aug 15, 2025	$0.61vs $0.15+508.7%	$13Mvs $11M+19.4%
Q2 2025	May 13, 2025	$0.20vs $0.24+183.2%	$16Mvs $8M+101.0%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
BCYCBicycle Therapeutics plcDirect Competitor	356.7M	5.15	-1.63	105.77%	-344.95%	-35.74%	0.03
PRTCPureTech Health plcDirect Competitor	41.04M	17.01	-0.37	-3.5%	-6.25%	-16.12%	0.06
NUVBNuvation Bio Inc.Direct Competitor	1.75B	5.04	-8.40	6.99%	-102.06%	-44.1%	0.03
RCUSArcus Biosciences, Inc.Product Competitor	2.62B	26.00	-7.90	-4.26%	-156.36%	-68.97%	0.16
PRAXPraxis Precision Medicines, Inc.Product Competitor	7.61B	337.95	-25.07	-100%		-58.74%	0.00
ANABAnaptysBio, Inc.Product Competitor	2.9B	67.36	-146.43	157.01%	-5.64%	-24.49%	0.38
IMVTImmunovant, Inc.Product Competitor	5.83B	28.67	-10.50			-47.07%	0.00
ABBVAbbVie Inc.Supply Chain	362.56B	204.98	86.49	8.57%	6.91%	62.15%

Compare XOMAP vs Peers

XOMA Corporation (XOMAP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs BCYC

Most directly comparable listed peer for XOMAP.

Scale Benchmark

vs ABBV

Larger-name benchmark to compare XOMAP against a more recognizable public peer.

Peer Set

Compare Top 5

vs BCYC, PRTC, NUVB, RCUS

XOMAP Income Statement

XOMA Corporation (XOMAP) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	52.69M	5.3M	18.37M	29.39M	38.16M	6.03M	4.76M	28.49M	52.15M
Revenue Growth %	846.98%	-89.94%	246.67%	59.96%	29.86%	-84.21%	-21.06%	498.72%	83.06%
Cost of Goods Sold	7.88M	1.68M	1.25M	170K	171K	274K	143K	206K	2.96M
COGS % of Revenue	14.95%	31.74%	6.82%	0.58%	0.45%	4.55%	3.01%	0.72%	5.68%
Gross Profit	44.81M▲ 0%	3.62M▼ 91.9%	17.12M▲ 373.2%	29.21M▲ 70.7%	37.99M▲ 30.0%	5.75M▼ 84.9%	4.62M▼ 19.8%	28.28M▲ 512.8%	49.19M▲ 73.9%
Gross Margin %	85.05%	68.26%	93.18%	99.42%	99.55%	95.45%	96.99%	99.28%	94.32%
Gross Profit Growth %	976.25%	-91.93%	373.24%	70.68%	30.03%	-84.86%	-19.78%	512.81%	73.93%
Operating Expenses	32.21M	20.25M	21M	16.8M	20.46M	23.17M	46.46M	68.26M	37.8M
OpEx % of Revenue	61.13%	382.05%	114.33%	57.17%	53.62%	384.39%	976.52%	239.61%	72.49%
Selling, General & Admin	24.34M	18.56M	21M	16.8M	20.46M	23.19M	27.18M	34.48M	36.09M
SG&A % of Revenue	46.19%	350.31%	114.33%	57.17%	53.62%	384.79%	571.27%	121.03%	69.21%
Research & Development	7.88M	1.68M	1.25M	170K	171K	153K	143K	2.88M	1.71M
R&D % of Revenue	14.95%	31.74%	6.82%	0.58%	0.45%	2.54%	3.01%	10.09%	3.28%
Other Operating Expenses	1.11M	4.34M	-1.25M	-170K	-171K	-177K	19.14M	30.9M	0
Operating Income	17.03M▲ 0%	-16.86M▼ 199.0%	-3.88M▲ 77.0%	12.42M▲ 419.6%	17.53M▲ 41.2%	-17.41M▼ 199.3%	-41.85M▼ 140.3%	-39.98M▲ 4.5%	11.38M▲ 128.5%
Operating Margin %	32.32%	-318.12%	-21.15%	42.25%	45.94%	-288.93%	-879.53%	-140.33%	21.83%
Operating Income Growth %	127.67%	-198.98%	76.95%	419.59%	41.18%	-199.34%	-140.31%	4.47%	128.48%
EBITDA	17.34M	-16.83M	-1.97M	12.59M	17.54M	-17.14M	-40.95M	-39.76M	14.36M
EBITDA Margin %	32.9%	-317.55%	-10.72%	42.84%	45.95%	-284.39%	-860.61%	-139.57%	27.53%
EBITDA Growth %	128.52%	-197.07%	88.29%	738.98%	39.31%	-197.74%	-138.9%	2.9%	136.11%
D&A (Non-Cash Add-back)	304K	30K	1.92M	172K	7K	274K	900K	216K	2.97M
EBIT	17.49M	-12.56M	-63K	13.64M	17.53M	-17.12M	-23.46M	-5.64M	11.38M
Net Interest Income	-1.24M	-922K	-1.92M	-1.84M	-461K	694K	-569K	-13.84M	-9.56M
Interest Income	0	0	0	0	0	694K	0	0	3.47M
Interest Expense	1.24M	922K	1.92M	1.84M	461K	0	569K	13.84M	13.03M
Other Income/Expense	-773K	3.42M	1.9M	-619K	-1.64M	295K	1.02M	20.5M	20.43M
Pretax Income	16.26M▲ 0%	-13.44M▼ 182.7%	-1.98M▲ 85.3%	11.8M▲ 695.2%	15.89M▲ 34.7%	-17.12M▼ 207.7%	-40.83M▼ 138.5%	-19.48M▲ 52.3%	31.82M▲ 263.3%
Pretax Margin %	30.86%	-253.65%	-10.79%	40.15%	41.64%	-284.04%	-858.15%	-68.38%	61.01%
Income Tax	1.66M	-98K	0	-1.5M	91K	-15K	0	-5.66M	103K
Effective Tax Rate %	10.22%	0.73%	0%	-12.72%	0.57%	0.09%	0%	29.05%	0.32%
Net Income	14.6M▲ 0%	-13.34M▼ 191.4%	-1.98M▲ 85.1%	13.3M▲ 770.9%	15.8M▲ 18.8%	-17.1M▼ 208.3%	-40.83M▼ 138.7%	-13.82M▲ 66.2%	31.71M▲ 329.4%
Net Margin %	27.7%	-251.8%	-10.79%	45.25%	41.4%	-283.79%	-858.15%	-48.52%	60.81%
Net Income Growth %	127.27%	-191.42%	85.15%	770.94%	18.8%	-208.27%	-138.72%	66.15%	329.45%
Net Income (Continuing)	14.6M	-13.34M	-1.98M	13.3M	15.8M	-17.1M	-40.83M	-13.82M	31.71M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.73▲ 0%	-1.18▼ 261.6%	-0.88▲ 25.4%	0.78▲ 188.6%	0.65▼ 16.7%	-1.98▼ 404.6%	-4.04▼ 104.0%	-1.65▲ 59.2%	1.46▲ 188.5%
EPS Growth %	115.47%	-261.64%	25.42%	188.64%	-16.67%	-404.62%	-104.04%	59.16%	188.48%
EPS (Basic)	0.75	-1.18	-0.88	0.82	0.69	-1.98	-4.04	-1.65	1.53
Diluted Shares Outstanding	11.33M	11.33M	8.76M	11.5M	12.19M	11.41M	11.47M	11.7M	17.98M
Basic Shares Outstanding	11.33M	11.33M	8.76M	10.67M	11.29M	11.41M	11.47M	11.7M	17.98M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-

XOMAP Balance Sheet

XOMA Corporation (XOMAP) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	44.2M	47.63M	59.97M	88.06M	96.97M	61.25M	169.31M	125.6M	117.26M
Cash & Short-Term Investments	43.47M	45.78M	56.69M	84.22M	94.1M	58.16M	153.45M	105.18M	82.91M
Cash Only	43.47M	45.78M	56.69M	84.22M	93.33M	57.83M	153.29M	101.65M	82.91M
Short-Term Investments	0	0	0	0	774K	335K	161K	3.53M	382K
Accounts Receivable	397K	1.47M	2.93M	1.79M	209K	2.37M	15.22M	17.02M	4.9M
Days Sales Outstanding	2.75	101.12	58.28	22.22	2	143.35	1.17K	218.01	34.27
Inventory	0	0	0	1.61M	0	0	0	0	0
Days Inventory Outstanding	-	-	-	3.46K	-	-	-	-	-
Other Current Assets	327K	0	0	0	2.05M	725K	160K	1.33M	29.45M
Total Non-Current Assets	740K	16.16M	35.75M	37.22M	69.59M	79.13M	64.99M	95.67M	155.44M
Property, Plant & Equipment	83K	59K	544K	380K	213K	36K	403K	351K	277K
Fixed Asset Turnover	634.82x	89.81x	33.77x	77.33x	179.15x	167.42x	11.81x	81.16x	188.26x
Goodwill	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	15.15M	0	25.91M	44.76M
Long-Term Investments	0	392K	681K	1.69M	0	63.68M	64.05M	0	106.38M
Other Non-Current Assets	657K	15.71M	34.53M	35.15M	69.38M	63.94M	533K	69.41M	4.03M
Total Assets	44.94M▲ 0%	63.78M▲ 41.9%	95.72M▲ 50.1%	125.28M▲ 30.9%	166.56M▲ 32.9%	140.38M▼ 15.7%	234.3M▲ 66.9%	221.28M▼ 5.6%	272.7M▲ 23.2%
Asset Turnover	1.17x	0.08x	0.19x	0.23x	0.23x	0.04x	0.02x	0.13x	0.19x
Asset Growth %	56.69%	41.95%	50.07%	30.88%	32.95%	-15.72%	66.9%	-5.56%	23.24%
Total Current Liabilities	7.42M	5.7M	8.88M	12.3M	12.97M	6.82M	19.5M	24.37M	34.82M
Accounts Payable	1.68M	1.24M	614K	456K	1.07M	524K	653K	1.05M	2.21M
Days Payables Outstanding	77.82	269.95	178.86	979.06	2.29K	698.03	1.67K	1.87K	272.18
Short-Term Debt	0	789K	5.18M	8.09M	0	0	5.54M	11.39M	14.99M
Deferred Revenue (Current)	1.41M	1.29M	1.89M	1.45M	1.64M	1.9M	2.11M	1.36M	1.27M
Other Current Liabilities	1.99M	2.08M	132K	1.56M	8.13M	2.35M	9.78M	3M	14.93M
Current Ratio	5.95x	8.35x	6.76x	7.16x	7.48x	8.98x	8.68x	5.15x	3.37x
Quick Ratio	5.95x	8.35x	6.76x	7.03x	7.48x	8.98x	8.68x	5.15x	3.37x
Cash Conversion Cycle	-	-	-	2.5K	-	-	-	-	-
Total Non-Current Liabilities	31.73M	39.3M	42.86M	26.56M	11.72M	9.55M	126.08M	114.98M	133.92M
Long-Term Debt	14.57M	21.69M	27.09M	12.76M	0	0	118.52M	106.88M	116.56M
Capital Lease Obligations	0	0	408K	229K	34K	0	335K	483K	0
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	103K
Other Non-Current Liabilities	32K	590K	43K	50K	0	0	0	3.21M	14.06M
Total Liabilities	39.15M	45M	51.74M	38.86M	24.69M	16.37M	145.58M	139.36M	168.74M
Total Debt	14.57M	22.48M	32.85M	21.26M	229K	34K	124.45M	119.2M	131.56M
Net Debt	-28.9M	-23.3M	-23.84M	-62.96M	-93.1M	-57.79M	-28.84M	17.54M	48.65M
Debt / Equity	2.52x	1.20x	0.75x	0.25x	0.00x	0.00x	1.40x	1.46x	1.27x
Debt / EBITDA	0.84x	-	-	1.69x	0.01x	-	-	-	9.16x
Net Debt / EBITDA	-1.67x	-	-	-5.00x	-5.31x	-	-	-	3.39x
Interest Coverage	14.13x	-13.62x	-0.03x	7.40x	38.02x	-	-41.24x	-0.41x	0.87x
Total Equity	5.79M▲ 0%	18.79M▲ 224.7%	43.99M▲ 134.2%	86.42M▲ 96.5%	141.88M▲ 64.2%	124.01M▼ 12.6%	88.72M▼ 28.5%	81.92M▼ 7.7%	103.96M▲ 26.9%
Equity Growth %	112.26%	224.66%	134.17%	96.47%	64.16%	-12.59%	-28.46%	-7.66%	26.9%
Book Value per Share	0.51	1.66	5.02	7.51	11.64	10.87	7.73	7.00	5.78
Total Shareholders' Equity	5.79M	18.79M	43.99M	86.42M	141.88M	124.01M	88.72M	81.92M	103.96M
Common Stock	62K	65K	73K	84K	85K	86K	86K	90K	89K
Retained Earnings	-1.18B	-1.19B	-1.19B	-1.18B	-1.17B	-1.18B	-1.22B	-1.24B	-1.22B
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-41K	0	0	0	0	0	0	73K	53K
Minority Interest	0	0	0	0	0	0	0	0	0

XOMAP Cash Flow Statement

XOMA Corporation (XOMAP) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	2.69M	-12.64M	-285K	10.09M	22.68M	-12.88M	-18.16M	-13.75M	2.87M
Operating CF Margin %	5.1%	-238.61%	-1.55%	34.34%	59.43%	-213.69%	-381.63%	-48.26%	5.51%
Operating CF Growth %	107.97%	-570.74%	97.75%	3641.05%	124.71%	-156.79%	-40.99%	24.29%	120.88%
Net Income	14.6M	-13.34M	-1.98M	13.3M	15.8M	-17.1M	-40.83M	-13.82M	31.71M
Depreciation & Amortization	304K	30K	25K	22K	7K	104K	934K	216K	2.97M
Stock-Based Compensation	7.3M	3.9M	4.95M	3.96M	6.2M	3.61M	9.22M	10.31M	9.27M
Deferred Taxes	1.72M	0	-187K	0	0	0	0	-5.66M	103K
Other Non-Cash Items	-13.04M	-251K	1.01M	-7.38M	1.56M	694K	13.41M	-2.01M	-29.82M
Working Capital Changes	-8.2M	-2.98M	-4.09M	187K	-886K	-181K	-898K	-2.79M	-11.37M
Change in Receivables	169K	-1.03M	-1.56M	1.14M	1.58M	208K	-1M	-835K	-2.43M
Change in Inventory	0	0	1.56M	0	0	0	0	0	0
Change in Payables	-6.55M	-1.16M	-242K	-542K	765K	1.84M	0	1.6M	-10.6M
Cash from Investing	1.61M	-15.01M	-19.3M	-209K	-26.5M	-20.22M	-711K	-28.26M	50.89M
Capital Expenditures	-8K	-15.01M	-19.3M	-9K	-26.5M	-15.25M	-17K	-20K	0
CapEx % of Revenue	0.02%	283.19%	105.06%	0.03%	69.44%	252.98%	0.36%	0.07%	-
Acquisitions	1.61M	0	0	0	0	0	0	-1.25M	3.85M
Investments	-	-	-	-	-	-	-	-	-
Other Investing	1.61M	-15M	0	-200K	0	-4.97M	-694K	-23.75M	47.13M
Cash from Financing	13.26M	29.94M	30.49M	19.79M	12.84M	-4.45M	120.59M	-11.13M	-26.46M
Debt Issued (Net)	-16.43M	7.49M	8.55M	-5.31M	-4.25M	0	130M	-6.9M	-10.6M
Equity Issued (Net)	30.18M	22.33M	22M	24.6M	40M	0	-148K	-13K	-7.33M
Dividends Paid	0	0	0	0	-3.5M	-5.47M	-5.47M	-5.47M	-5.47M
Share Repurchases	0	0	0	0	0	0	-148K	-13K	-16.04M
Other Financing	-490K	120K	-54K	506K	-19.42M	1.02M	-3.79M	1.26M	-3.07M
Net Change in Cash	17.73M▲ 0%	2.31M▼ 87.0%	10.91M▲ 372.4%	29.68M▲ 172.1%	9.01M▼ 69.6%	-37.55M▼ 516.6%	101.72M▲ 370.9%	-53.13M▼ 152.2%	27.29M▲ 151.4%
Free Cash Flow	2.68M▲ 0%	-27.65M▼ 1132.5%	-19.59M▲ 29.2%	8.88M▲ 145.4%	-3.82M▼ 143.0%	-28.13M▼ 635.9%	-18.18M▲ 35.4%	-13.77M▲ 24.2%	2.87M▲ 120.9%
FCF Margin %	5.08%	-521.8%	-106.61%	30.23%	-10.02%	-466.67%	-381.99%	-48.33%	5.51%
FCF Growth %	107.94%	-1132.49%	29.17%	145.36%	-143.03%	-635.9%	35.38%	24.25%	120.85%
FCF per Share	0.24	-2.44	-2.23	0.77	-0.31	-2.46	-1.58	-1.18	0.16
FCF Conversion (FCF/Net Income)	0.18x	0.95x	0.14x	0.76x	1.44x	0.75x	0.44x	0.99x	0.09x
Interest Paid	0	81K	0	692K	311K	0	0	9.98M	0
Taxes Paid	0	1.64M	0	0	0	76K	0	9.98M	0

XOMAP Key Ratios

XOMA Corporation (XOMAP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-	252.26%	-108.61%	-6.31%	20.39%	13.84%	-12.87%	-38.39%	-16.2%	34.12%
Return on Invested Capital (ROIC)	-	-	-	-37.28%	42.71%	36.4%	-22.71%	-49.78%	-37.63%	6.77%
Gross Margin	74.84%	85.05%	68.26%	93.18%	99.42%	99.55%	95.45%	96.99%	99.28%	94.32%
Net Margin	-962.08%	27.7%	-251.8%	-10.79%	45.25%	41.4%	-283.79%	-858.15%	-48.52%	60.81%
Debt / Equity	-	2.52x	1.20x	0.75x	0.25x	0.00x	0.00x	1.40x	1.46x	1.27x
Interest Coverage	-12.57x	14.13x	-13.62x	-0.03x	7.40x	38.02x	-	-41.24x	-0.41x	0.87x
FCF Conversion	0.63x	0.18x	0.95x	0.14x	0.76x	1.44x	0.75x	0.44x	0.99x	0.09x
Revenue Growth	-89.97%	846.98%	-89.94%	246.67%	59.96%	29.86%	-84.21%	-21.06%	498.72%	83.06%

XOMAP SEC Filings & Documents

XOMA Corporation (XOMAP) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 27, 2026·SEC

Material company update

Mar 18, 2026·SEC

Material company update

Mar 2, 2026·SEC

10-K Annual Reports

FY 2026

Mar 18, 2026·SEC

FY 2025

Mar 17, 2025·SEC

FY 2024

Mar 8, 2024·SEC

10-Q Quarterly Reports

FY 2025

Nov 12, 2025·SEC

FY 2025

Aug 13, 2025·SEC

FY 2025

May 13, 2025·SEC

XOMAP Frequently Asked Questions

XOMA Corporation (XOMAP) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

XOMA Corporation (XOMAP) reported $52.1M in revenue for fiscal year 2025. This represents a 1349% increase from $3.6M in 1996.

XOMA Corporation (XOMAP) grew revenue by 83.1% over the past year. This is strong growth.

Yes, XOMA Corporation (XOMAP) is profitable, generating $31.7M in net income for fiscal year 2025 (60.8% net margin).

Dividend & Returns

Yes, XOMA Corporation (XOMAP) pays a dividend with a yield of 1.20%. This makes it attractive for income-focused investors.

XOMA Corporation (XOMAP) has a return on equity (ROE) of 34.1%. This is excellent, indicating efficient use of shareholder capital.

XOMA Corporation (XOMAP) generated $2.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More XOMAP

XOMA Corporation (XOMAP) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

XOMA Corporation(XOMAP)Earnings, Financials & Key Ratios

XOMAP Key Insights

✓Strengths

✗Weaknesses

XOMAP Price & Volume

XOMAP Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

XOMAP Recent Earnings

XOMAP Peer Comparison

Compare XOMAP vs Peers

vs BCYC

vs ABBV

Compare Top 5

XOMAP Income Statement

XOMAP Balance Sheet

XOMAP Cash Flow Statement

XOMAP Key Ratios

XOMAP SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

XOMAP Frequently Asked Questions

Explore More XOMAP

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation